Cholesterol, triglyceride, and lipoprotein studies: Strategies for clinical use
- 1 March 1980
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 67 (3) , 263-273
- https://doi.org/10.1080/00325481.1980.11715408
Abstract
Epidemiologic evidence links high levels of low density lipoprotein (LDL) cholesterol and low levels of high density lipoprotein (HDL) cholesterol to increased risk of coronary heart disease. There is no evidence--yet--that lowering LDL and raising HDL alleviate that risk. Testing should be limited to those subgroups of the population at greatest risk. Total cholesterol and triglyceride determinations are the tests of choice for initial evaluation. HDL should be determined before instituting long-term treatment for hypercholesterolemia.Keywords
This publication has 18 references indexed in Scilit:
- WHY BLAME CHOLESTEROL?The Lancet, 1979
- IS THE SERUM TOTAL CHOLESTEROL AN ANACHRONISM?The Lancet, 1979
- Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.Journal of Clinical Pathology, 1979
- High-density lipoproteins, cholesterol transport and coronary heart disease.Circulation, 1979
- Coronary disease: Risk factors, age, and timeAmerican Heart Journal, 1979
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- A general cardiovascular risk profile: The Framingham studyThe American Journal of Cardiology, 1976
- The common hyperlipidaemiasPublished by Oxford University Press (OUP) ,1976
- It's time to be practical.Circulation, 1975
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975